NextBio, a US-based provider of life sciences software, has announced that it has closed an $8 million Series C round of financing led by existing investor Newbury Ventures. Various other private investors participated in the round. Nextbio offers a platform that enables life science researchers to search, discover and share knowledge from public and proprietary data.
The company will use the capital to expand sales reach and channels, global operations, and in technology. Since its launch, NextBio's research platform has been adopted for use by researchers at many of the world's top commercial and academic institutions, according to the company. It recently partnered with STM publisher Elsevier to offer NextBio to subscribers of ScienceDirect.
NextBio's platform is claimed to seamlessly combine powerful tools with correlated content to transform information into knowledge, providing the foundation for new scientific discoveries. It is delivered as a SaaS (Software as a Service) solution, resulting in quick deployment and rapid return on investment.
Search for more such Search tools in K-Store
Discuss this NEWS
